StockSelector.com
  Research, Select, & Monitor Thursday, November 21, 2019 7:56:10 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
TherapeuticsMD, Inc.$2.67$.083.09%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

TherapeuticsMD, Inc. has an overall rank of 1604 out of 7176 stocks based on 12 positive rankings and 6 negative rankings.

Positive Rankings
Estimated Revenue Growth
TherapeuticsMD rank is 36
Target Prices
The average analysts' target price is $7.00 for TherapeuticsMD using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, TherapeuticsMD is ranked 54.
SSValue
The StockSelector Value for TherapeuticsMD is $15.24. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, TherapeuticsMD is ranked 171.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, TherapeuticsMD is ranked 441.
Up EPS Surprise
TherapeuticsMD beat the consensus earnings estimate when it last reported quarterly earnings.
Low vPut/Call
TherapeuticsMD has a low Put/Call ratio of 0.34 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, TherapeuticsMD is ranked 700.
Highest Cash Growth
TherapeuticsMD rank is 833
Low Put/Call
TherapeuticsMD has a low Put/Call ratio of 0.37 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, TherapeuticsMD is ranked 935.
90 Day Gain
TherapeuticsMD rank is 1094
Historic Revenue Growth
TherapeuticsMD rank is 1107
10 Day Gain
TherapeuticsMD rank is 1340
Debt-to-Equity
TherapeuticsMD rank is 2340
Negative Rankings
Negative ROE
TherapeuticsMD rank is 296
Negative Net Margin
TherapeuticsMD rank is 299
Price-to-Sales
TherapeuticsMD rank is 319
Negative ROA
TherapeuticsMD rank is 451
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, TherapeuticsMD is ranked 657.
Price-to-Book
TherapeuticsMD rank is 708







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.